APO RESEARCH · REPORT
Ibuprofen
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Product & engineering
Understand the product.
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Selected research
Market Structure
Global Ibuprofen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.
China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30%.
Read the full market overview
North America is the largest sales place, with a sales market share nearly 29%. Following North America, Europe is the second largest sales place with the sales market share of 26%.
The classification of Ibuprofen includes USP and EP and the sales proportion of USP Ibuprofen is about 65%.
Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen is used in Tablet, and the market share is about 46%.
This report provides an overview of the global Ibuprofen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ibuprofen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ibuprofen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ibuprofen market size, projected growth trends, production technologies, key applications, and end-use industries.
Ibuprofen Segment by Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar
Ibuprofen Segment by Type
USP
EP
Ibuprofen Segment by Application
Tablet
Capsule
Suspension
Others
Ibuprofen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ibuprofen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ibuprofen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ibuprofen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ibuprofen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ibuprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ibuprofen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ibuprofen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- USP
- EP
Applications
- Tablet
- Capsule
- Suspension
- Others
Companies covered
- Xinhua Pharmaceutical
- IOLCP
- Granules Biocause
- Strides Shasun
- BASF
- SI Group
- Xinhua-Perrigo Pharmaceutical
- Hisoar
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ibuprofen Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ibuprofen Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ibuprofen Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ibuprofen Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ibuprofen Market Dynamics
- 2.1 Ibuprofen Industry Trends
- 2.2 Ibuprofen Industry Drivers
- 2.3 Ibuprofen Industry Opportunities and Challenges
- 2.4 Ibuprofen Industry Restraints
3 Ibuprofen Market by Manufacturers
- 3.1 Global Ibuprofen Revenue by Manufacturers (2021-2026)
- 3.2 Global Ibuprofen Sales by Manufacturers (2021-2026)
- 3.3 Global Ibuprofen Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ibuprofen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ibuprofen Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ibuprofen Manufacturers, Product Type & Application
- 3.7 Global Ibuprofen Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ibuprofen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ibuprofen Players Market Share by Revenue in 2025
- 3.8.3 2025 Ibuprofen Tier 1, Tier 2, and Tier 3
4 Ibuprofen Market by Type
- 4.1 Ibuprofen Type Introduction
- 4.1.1 USP
- 4.1.2 EP
- 4.2 Global Ibuprofen Sales by Type
- 4.2.1 Global Ibuprofen Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ibuprofen Sales by Type (2021-2032)
- 4.2.3 Global Ibuprofen Sales Market Share by Type (2021-2032)
- 4.3 Global Ibuprofen Revenue by Type
- 4.3.1 Global Ibuprofen Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ibuprofen Revenue by Type (2021-2032)
- 4.3.3 Global Ibuprofen Revenue Market Share by Type (2021-2032)
5 Ibuprofen Market by Application
- 5.1 Ibuprofen Application Introduction
- 5.1.1 Tablet
- 5.1.2 Capsule
- 5.1.3 Suspension
- 5.1.4 Others
- 5.2 Global Ibuprofen Sales by Application
- 5.2.1 Global Ibuprofen Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ibuprofen Sales by Application (2021-2032)
- 5.2.3 Global Ibuprofen Sales Market Share by Application (2021-2032)
- 5.3 Global Ibuprofen Revenue by Application
- 5.3.1 Global Ibuprofen Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ibuprofen Revenue by Application (2021-2032)
- 5.3.3 Global Ibuprofen Revenue Market Share by Application (2021-2032)
6 Global Ibuprofen Sales by Region
- 6.1 Global Ibuprofen Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ibuprofen Sales by Region (2021-2032)
- 6.2.1 Global Ibuprofen Sales by Region (2021-2026)
- 6.2.2 Global Ibuprofen Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ibuprofen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ibuprofen Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ibuprofen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ibuprofen Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ibuprofen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ibuprofen Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ibuprofen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ibuprofen Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ibuprofen Revenue by Region
- 7.1 Global Ibuprofen Revenue by Region
- 7.1.1 Global Ibuprofen Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ibuprofen Revenue by Region (2021-2026)
- 7.1.3 Global Ibuprofen Revenue by Region (2027-2032)
- 7.1.4 Global Ibuprofen Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ibuprofen Revenue (2021-2032)
- 7.2.2 North America Ibuprofen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ibuprofen Revenue (2021-2032)
- 7.3.2 Europe Ibuprofen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ibuprofen Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ibuprofen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ibuprofen Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ibuprofen Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Xinhua Pharmaceutical
- 8.1.1 Xinhua Pharmaceutical Company Information
- 8.1.2 Xinhua Pharmaceutical Business Overview
- 8.1.3 Xinhua Pharmaceutical Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Xinhua Pharmaceutical Ibuprofen Product Portfolio
- 8.1.5 Xinhua Pharmaceutical Recent Developments
- 8.2 IOLCP
- 8.2.1 IOLCP Company Information
- 8.2.2 IOLCP Business Overview
- 8.2.3 IOLCP Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 IOLCP Ibuprofen Product Portfolio
- 8.2.5 IOLCP Recent Developments
- 8.3 Granules Biocause
- 8.3.1 Granules Biocause Company Information
- 8.3.2 Granules Biocause Business Overview
- 8.3.3 Granules Biocause Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Granules Biocause Ibuprofen Product Portfolio
- 8.3.5 Granules Biocause Recent Developments
- 8.4 Strides Shasun
- 8.4.1 Strides Shasun Company Information
- 8.4.2 Strides Shasun Business Overview
- 8.4.3 Strides Shasun Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Strides Shasun Ibuprofen Product Portfolio
- 8.4.5 Strides Shasun Recent Developments
- 8.5 BASF
- 8.5.1 BASF Company Information
- 8.5.2 BASF Business Overview
- 8.5.3 BASF Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 BASF Ibuprofen Product Portfolio
- 8.5.5 BASF Recent Developments
- 8.6 SI Group
- 8.6.1 SI Group Company Information
- 8.6.2 SI Group Business Overview
- 8.6.3 SI Group Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 SI Group Ibuprofen Product Portfolio
- 8.6.5 SI Group Recent Developments
- 8.7 Xinhua-Perrigo Pharmaceutical
- 8.7.1 Xinhua-Perrigo Pharmaceutical Company Information
- 8.7.2 Xinhua-Perrigo Pharmaceutical Business Overview
- 8.7.3 Xinhua-Perrigo Pharmaceutical Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Xinhua-Perrigo Pharmaceutical Ibuprofen Product Portfolio
- 8.7.5 Xinhua-Perrigo Pharmaceutical Recent Developments
- 8.8 Hisoar
- 8.8.1 Hisoar Company Information
- 8.8.2 Hisoar Business Overview
- 8.8.3 Hisoar Ibuprofen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hisoar Ibuprofen Product Portfolio
- 8.8.5 Hisoar Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ibuprofen Value Chain Analysis
- 9.1.1 Ibuprofen Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ibuprofen Production Mode & Process
- 9.2 Ibuprofen Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ibuprofen Distributors
- 9.2.3 Ibuprofen Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst